Gynecologic Oncology Practice Questions

Q: A 45-year-old patient presents to the Gynecology OPD with a history of postcoital bleeding. She underwent the procedure shown below. Name the instruments used.

Ayre's spatula, Cusco's speculum. ***Ayre's spatula, Cusco's speculum*** - **Ayre's spatula** is the standard instrument for collecting **ectocervical cells** during a Pap smear, essential for screening cervical cancer in patients with postcoital bleeding. - **Cusco's speculum** provides optimal **visualization** and **access** to the cervix, allowing proper sample collection from the transformation zone. *Cervical pipette, Sim's speculum* - **Cervical pipette** is primarily used for **endometrial sampling**, not for routine cervical cytology screening. - **Sim's speculum** is a **single-blade speculum** that provides limited visualization compared to the bivalve Cusco's speculum. *Endocervical brush, Sim's speculum* - **Endocervical brush** alone is insufficient as it only samples the **endocervical canal**, missing the important **ectocervical** transformation zone. - **Sim's speculum** offers **inadequate exposure** of the cervix for proper cytological sampling. *Cusco's speculum, Endocervical brush* - While **Cusco's speculum** is correct, using only an **endocervical brush** misses the **ectocervical** cells from the transformation zone. - **Ayre's spatula** is essential for collecting cells from the **squamocolumnar junction** where most cervical cancers originate.

Q: For a woman with a history of two prior molar pregnancies, what is the risk of having a third molar pregnancy?

20%. **Explanation:** The risk of recurrent gestational trophoblastic disease (GTD) increases significantly with each subsequent molar pregnancy. This question tests the candidate's knowledge of the specific statistical progression of recurrence risk. **1. Why 20% is Correct:** The baseline risk of a molar pregnancy in the general population is approximately **0.1% (1 in 1000)**. * After **one** molar pregnancy, the risk of recurrence rises to **1%** (a 10-fold increase). * After **two** prior molar pregnancies, the risk jumps significantly to **15–20%**. This exponential increase is likely due to underlying genetic predispositions or oocyte defects that favor abnormal fertilization. **2. Analysis of Incorrect Options:** * **A (1%):** This is the risk of recurrence after only **one** prior molar pregnancy. * **B (5%) & C (10%):** These values underestimate the risk. While recurrence risks for many obstetric complications (like preeclampsia) fall in this range, molar pregnancy recurrence follows a much steeper trajectory after the second event. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Most Common Type:** The most common karyotype for a **Complete Mole** is 46,XX (androgenetic), while a **Partial Mole** is typically 69,XXX or 69,XXY (triploid). * **Management of Future Pregnancies:** For patients with a history of mole, an early ultrasound (6–10 weeks) is mandatory in all subsequent pregnancies to confirm normalcy. * **Post-Evacuation Monitoring:** After evacuation, serum β-hCG should be monitored weekly until three consecutive negative results are obtained, then monthly (6 months for complete mole). * **Contraception:** Combined Oral Contraceptive Pills (OCPs) are the preferred method once hCG levels become undetectable; they do not increase the risk of post-molar trophoblastic neoplasia.

Q: A dermoid cyst of the ovary contains derivatives from which germ layer(s)?

All. **Explanation:** A **Dermoid Cyst**, also known as a **Mature Cystic Teratoma**, is the most common germ cell tumor of the ovary. By definition, a teratoma is a tumor composed of tissues derived from more than one germ cell layer, and in the case of a dermoid cyst, it characteristically contains well-differentiated tissues from **all three germ layers**: 1. **Ectoderm:** This is the most prominent layer, giving rise to skin, hair follicles, sebaceous glands (producing the characteristic "cheesy" sebum), and neural tissue. 2. **Mesoderm:** Represented by bone, cartilage, teeth, muscle, and fat. 3. **Endoderm:** Represented by respiratory epithelium, gastrointestinal tract lining, and thyroid tissue. **Why other options are incorrect:** Options A, B, and C are incomplete. While a dermoid cyst does contain ectodermal, mesodermal, and endodermal elements, selecting only one would ignore its defining characteristic as a multi-germ layer tumor. **Clinical Pearls for NEET-PG:** * **Most Common Complication:** Torsion (due to its heavy weight and long pedicle). * **Most Common Malignant Transformation:** Squamous cell carcinoma (occurring in <2% of cases, usually in postmenopausal women). * **Radiological Sign:** Presence of teeth or calcification on X-ray/CT; "Rokitansky protuberance" (dermoid plug) on Ultrasound. * **Struma Ovarii:** A specialized teratoma composed predominantly of thyroid tissue (endoderm), which can lead to thyrotoxicosis. * **Chemical Peritonitis:** Occurs if the cyst ruptures and spills its sebaceous contents into the peritoneal cavity.

Q: A patient with carcinoma of the cervix, who has completed radiotherapy, presents with uremia. What is the most common cause of this presentation?

Bilateral ureteral invasion. **Explanation:** In advanced carcinoma of the cervix, the most common cause of death and a frequent cause of renal failure (uremia) is **bilateral ureteral obstruction**. **1. Why Option A is Correct:** Cervical cancer typically spreads laterally via the parametrium. As the tumor infiltrates the parametrial tissues, it can compress or directly invade the ureters at the point where they pass under the uterine artery ("water under the bridge"). When this occurs bilaterally, it leads to obstructive uropathy, hydronephrosis, and eventually uremia. Even after radiotherapy, persistent or recurrent disease is the most statistically likely cause of new-onset uremia in these patients. **2. Why Other Options are Incorrect:** * **Radiation Nephritis (B):** This occurs when the kidneys are directly in the radiation field (e.g., treating upper abdominal tumors). In cervical cancer, the radiation is focused on the pelvis, sparing the kidneys. * **Ureteral Stenosis due to Radiation (C):** While radiation-induced fibrosis can cause ureteral strictures, it is significantly less common than direct tumor invasion or recurrence. * **Unconnected Causes (D):** While possible, they are not the "most common" cause in the context of a known cervical malignancy. **Clinical Pearls for NEET-PG:** * **Most common cause of death in Cervical CA:** Uremia (Renal failure) due to bilateral ureteral obstruction. * **Staging Significance:** Ureteral involvement (hydronephrosis or non-functioning kidney) automatically classifies the disease as **Stage IIIB**, regardless of other findings. * **Triad of Advanced Pelvic Malignancy:** Leg edema, hydronephrosis, and sciatic pain (indicates lateral pelvic wall involvement).

Q: What is the characteristic color of the vulva in Paget's disease?

White. **Explanation:** **Extramammary Paget’s Disease (EMPD)** of the vulva is a rare intraepithelial neoplasia. While the classic clinical description often mentions a "cake-icing" appearance with red, eczematous patches, the characteristic finding emphasized in competitive exams like NEET-PG is the presence of **white, hyperkeratotic plaques** interspersed within these red areas. This creates a variegated, "red and white" map-like appearance. The "white" component is due to the presence of thickened, keratinized epithelium or the accumulation of Paget cells. **Analysis of Options:** * **White (Correct):** The hallmark of Paget’s is the "porcelain-white" or "cake-icing" plaque. In the context of standard PG entrance exams, "White" is the preferred answer to describe the characteristic leukoplakic patches. * **Blue:** This is incorrect. Blue/black lesions on the vulva are more characteristic of **Malignant Melanoma** or benign nevi. * **Red:** While the background of Paget’s is often erythematous (eczematoid), "Red" alone is non-specific and can mimic simple dermatitis or candidiasis. The diagnostic "clue" is the white plaque. * **Yellow:** This is not a feature of Paget’s; yellow discharge or crusting is more typical of secondary bacterial infections (impetiginization). **Clinical Pearls for NEET-PG:** * **Histology:** Pathognomonic **Paget cells** (large, pale cells with abundant granular cytoplasm and large nuclei) are found in the epidermis. * **Staining:** Paget cells are **PAS positive**, **Alcian Blue positive**, and **Mucicarmine positive** (indicating mucin production). * **Associated Malignancy:** Unlike mammary Paget’s, vulvar Paget’s is less frequently associated with an underlying adenocarcinoma (about 20-30%), but a thorough search for internal malignancy (rectal, bladder, or cervical) is mandatory. * **Treatment:** Wide local excision is the gold standard, though recurrence rates are high due to "skip lesions."

Q: Carcinoma of the cervix extends to the lateral pelvic wall. What is the clinical stage?

Stage III. **Explanation:** The clinical staging of cervical cancer follows the **FIGO (2018) classification**. The correct answer is **Stage III** because, by definition, this stage involves the lower third of the vagina, extension to the pelvic wall, and/or causes hydronephrosis or a non-functioning kidney. **Breakdown of the Correct Answer:** * **Stage IIIB:** Specifically refers to cases where the tumor extends to the **pelvic sidewall** and/or causes hydronephrosis or a non-functioning kidney. On rectal examination, there is no cancer-free space between the tumor and the pelvic wall. **Why the other options are incorrect:** * **Stage I:** The carcinoma is strictly confined to the cervix (neck of the uterus). It has not spread to the vagina or parametrium. * **Stage II:** The tumor extends beyond the uterus but has **not** reached the pelvic sidewall or the lower third of the vagina. Stage IIB involves the parametrium but spares the pelvic wall. * **Stage IV:** This represents advanced disease where the tumor has invaded the mucosa of the bladder or rectum (IVA) or has spread to distant organs (IVB). **High-Yield Clinical Pearls for NEET-PG:** * **Staging Method:** FIGO staging for cervical cancer is primarily **clinical** (physical exam, cystoscopy, proctoscopy), but the 2018 update now allows the use of **imaging** (MRI/CT/PET) and **pathology** to assign the stage. * **Parametrial Involvement:** If the parametrium is involved but the pelvic wall is free, it is **Stage IIB**. Once it hits the pelvic wall, it becomes **Stage IIIB**. * **Hydronephrosis:** Any patient with cervical cancer and hydronephrosis is automatically categorized as **Stage IIIB**, regardless of other findings. * **Lymph Nodes:** Under FIGO 2018, involvement of pelvic or para-aortic lymph nodes is classified as **Stage IIIC**.

Q: A 52-year-old postmenopausal woman presents with vaginal bleeding for 3 weeks. She is concerned this could be cancer, similar to her sister's condition. Transvaginal ultrasound reveals an endometrial thickness of 8.0 mm. What is the next step in management?

Histopathological examination of curettage. **Explanation:** The clinical presentation of **postmenopausal bleeding (PMB)** is a "red flag" that must be investigated to rule out endometrial carcinoma. In a postmenopausal woman, the gold standard for diagnosis is obtaining a tissue sample for histopathological examination. 1. **Why Option C is correct:** According to standard protocols, any postmenopausal woman with vaginal bleeding and an **endometrial thickness (ET) > 4 mm** on transvaginal ultrasound (TVS) requires a tissue biopsy. In this patient, the ET is 8.0 mm, significantly exceeding the threshold. Histopathological examination (via endometrial biopsy or fractional curettage) is essential to differentiate between endometrial hyperplasia, polyps, or malignancy. 2. **Why other options are incorrect:** * **Option A (Hysterectomy):** This is a definitive surgical treatment, not a diagnostic step. It should only be performed after a confirmed diagnosis of malignancy or premalignant lesions. * **Option B (Steroid hormone therapy):** Hormonal therapy (like progestogens) may be used for hyperplasia without atypia, but it is contraindicated before a tissue diagnosis is established. * **Option D (Observation):** An ET of 8.0 mm in the presence of PMB is highly suspicious. Observation would lead to a delayed diagnosis of potential cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Cut-off for ET in PMB:** If ET is **≤ 4 mm**, the risk of malignancy is 4 mm**, biopsy is mandatory. * **Most common cause of PMB:** Senile (atrophic) vaginitis/endometritis. * **Most serious cause of PMB:** Endometrial carcinoma (found in ~10% of cases). * **Risk Factors:** Obesity, nulliparity, late menopause, and Lynch syndrome (relevant here due to the sister's history).

Question 1

A 45-year-old patient presents to the Gynecology OPD with a history of postcoital bleeding. She underwent the procedure shown below. Name the instruments used.

Accepted Answer

Ayre's spatula, Cusco's speculum

Answer

Cervical pipette, Sim's speculum

Answer

Endocervical brush, Sim's speculum

Answer

Cusco's speculum, Endocervical brush

Question 2

For a woman with a history of two prior molar pregnancies, what is the risk of having a third molar pregnancy?

Accepted Answer

20%

Answer

1%

Answer

5%

Answer

10%

Question 3

Conventional cytogenetics are difficult in solid tumors, especially in cases of carcinoma of the cervix, due to which of the following factors?

Accepted Answer

Inadequate biopsy specimen

Answer

High mitotic rate

Answer

Bacterial contamination of the specimen

Answer

Good metaphase activity

Question 4

Regarding adenocarcinoma in situ, all are true, except:

Accepted Answer

Negative margins on an excised specimen ensures complete resection of the disease.

Answer

Invasive cancer cannot be ruled out without diagnostic excisional procedures.

Answer

Hysterectomy is preferred for women who have completed childbearing.

Answer

Frequently extends into the endocervical canal.

Question 5

A 25-year-old woman undergoes a Pap smear at a screening camp for cervical cancer. Her test report indicates inadequate cervical cytology. What is the appropriate follow-up for this patient?

Accepted Answer

Repeat cervical cytology in 3 months

Answer

Refer for colposcopy

Answer

Repeat cervical cytology in 6 months

Answer

Repeat cervical cytology in 3 years

Question 6

A dermoid cyst of the ovary contains derivatives from which germ layer(s)?

Accepted Answer

All

Answer

Endoderm

Answer

Mesoderm

Answer

Ectoderm

Question 7

A patient with carcinoma of the cervix, who has completed radiotherapy, presents with uremia. What is the most common cause of this presentation?

Accepted Answer

Bilateral ureteral invasion

Answer

Radiation nephritis

Answer

Ureteral stenosis due to radiation

Answer

Unconnected causes

Question 8

What is the characteristic color of the vulva in Paget's disease?

Accepted Answer

White

Answer

Blue

Answer

Red

Answer

Yellow

Question 9

Carcinoma of the cervix extends to the lateral pelvic wall. What is the clinical stage?

Accepted Answer

Stage III

Answer

Stage I

Answer

Stage II

Answer

Stage IV

Question 10

A 52-year-old postmenopausal woman presents with vaginal bleeding for 3 weeks. She is concerned this could be cancer, similar to her sister's condition. Transvaginal ultrasound reveals an endometrial thickness of 8.0 mm. What is the next step in management?

Accepted Answer

Histopathological examination of curettage

Answer

Hysterectomy

Answer

Steroid hormone therapy

Answer

Observation and follow-up

Gynecologic Oncology — MCQs

Gynecologic Oncology — MCQs

On this page

Practice by Chapter

Want unlimited practice?